… grants from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which has made the validation of LRRK2 as a … potential disease-modifying target one of its key areas of research. Brian Fiske, PhD, director of research programs at … British Columbia, to implement a similar approach to look into genetically under-represented populations in areas such …

… The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces 39 new grant awards totaling more than $10 million. The selected projects reflect our research strategy to define, measure and treat Parkinson’s … disease. We also awarded grants to help develop the research tools the field needs to advance. All of our …

… on the strengths of both organizations, combining MJFF’s research expertise and PAN’s extensive knowledge of public … advocate and an MJFF supporter, everything I do is to speed research toward a cure for Parkinson’s disease. But there is … the lives of patients. We can’t conduct studies if federal research funding is cut. We can’t bring new drugs to market …

… results from a phase 1 safety trial of the drug sometime early next year.       At AFFiRiS, scientists with expertise … the clinic, AFFiRiS concluded pre-clinical laboratory work into PD01 to verify that the drug could be properly produced … in the latest of our monthly feature, Three Questions for a Researcher, to learn more about the AFFiRiS model, and to …

… global protein changes in different tissues. Impact on Diagnosis/Treatment of Parkinson's disease: This study will provide further insight into the role of protein modifications as indicators of … Research Tool … Research Grant …

… NEW YORK, NY - Research projects from five biopharmaceutical companies in … through the pipeline of drug development and eventually into patients' hands. Non-confidential overviews of the … contacts and more broadly via MJFF's Web site twice yearly in July and December (previously quarterly). Selected …